"HUMAN FRIENDLY MEDICINES"
-- MEDICINES THAT ACHIEVE BETTER QUALITY OF LIFE

"HUMAN FRIENDLY MEDICINES"-- MEDICINES THAT ACHIEVE BETTER QUALITY OF LIFE

Our corporate missions are develop and provide the prescribing doctors and then the patients in need with safer, more effective and easier-to-use medicines that are substantiated by the research and elucidation of pathology and etiology of the disease they are meant to treat, and by doing so contribute to the better quality of life and better pharmacoeconomics for the patient.

Some 200 R&D staffs vigorously carry out pre-clinical and clinical studies for the development of new medicines with primary emphasis on the advantage offered to patients as well as efficacy against the disease, strictly observing and respecting the current standards, guidelines and regulations.
To properly incorporate the fair and accurate clinical data and advice from doctors, everyday we discuss and process the information carefully. In this way, we develop and market medicines that help achieve a better quality of life and then create "New Value" to the market.

SANWA KAGAKU KENKYUSHO devotes itself for the development of pharmaceutical products with improved formulations and drug delivery systems to address the unmet needs of the health care professionals in such therapeutic areas of diabetes and cardiovascular diseases associated with diabetes, and further assumes a challenging mission of creating "drugs" that have unique power with excellent safety profiles.